Bluejay Diagnostics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BJDX | TRIB | CODX | ALBIO.PA | BMRA | BOUL.ST | |
|---|---|---|---|---|---|---|
| Market cap | 2.56M | 5.23M | 3.19M | 15.48M | 7.98M | 50.29M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -7.2 | -6.2 | -0.4 | 1.8 | 4.4 | 1.1 |
| Price/book | 0.1 | -0.1 | 0.1 | 0.4 | 2.2 | 0.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −92.02% | −77.91% | −96.77% | +56.67% | −34.11% | −86.51% |
| Today | +3.62% | −2.02% | −4.89% | +2.44% | +2.06% | +8.82% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All BJDX news ›Bluejay Diagnostics, Inc. (BJDX) Sets 1-for-4 Reverse Split Effective Nov. 3
Bluejay Diagnostics (BJDX) Sets 1-for-4 Reverse Split Effective Nov. 3 TradingView Bluejay Diagnostics, Inc. (BJDX) Sets 1-for-4 Reverse Split Effective Nov. 3 Bluejay Diagnostics approved a 1-for-4 reverse stock split effective 12:01 a.m.…
Bluejay Diagnostics, Inc. and Argonaut Manufacturing Services Announce Strategic Partnership
Bluejay Diagnostics, Inc. announced that it has entered into a strategic partnership with Argonaut Manufacturing Services to support the advancement of Bluejay?s Symphony? platform. This partnership... announced that it has entered into a…
Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in Symon-Ii Pivotal Clinical Trial
Bluejay Diagnostics, Inc. announced the successful enrollment of 624 patients in its ongoing SYMON-II Trial, a pivotal clinical study evaluating the Company?s Symphony platform for interleukin-6 ... announced the successful enrollment of…
Bluejay Diagnostics, Inc. and Lovell Government Services, Inc. Announce Partnership to Expand Access to U.S. Federal Healthcare Markets
Bluejay Diagnostics, Inc. announced that it has entered into a distribution, co-marketing and strategic partnership with Lovell Government Services, Inc. designed to support the introduction of... announced that it has entered into a…
Bluejay Diagnostics Advances Rapid Biomarker Testing For Sepsis Patients
Researchers investigate this biomarker to determine its connection with 28-day mortality risk among critically ill individuals suffering from sepsis and septic shock. Sepsis occurs when a bacterial, viral, or fungal infection causes a…
Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock
SYMON-II Clinical Validation Dataset Represents a Key Milestone as Bluejay Advances the Symphony™ IL-6 Test Toward Regulatory Submission The current preliminary SYMON-II analysis includes 777 evaluable patients, consisting of 637 28-day…
Bluejay Diagnostics reports SYMON-II dataset: 777 patients, ~18% 28-day mortality for IL-6 evaluation
TradingView Bluejay Diagnostics reports SYMON-II dataset: 777 patients, ~18% 28-day mortality for IL-6 evaluation Bluejay Diagnostics announced baseline SYMON-II data showing 777 evaluable patients
Bluejay Diagnostics, Inc. announced that it expects to receive $8.500007 million in funding
Bluejay Diagnostics, Inc. has entered into securities definitive agreements to issue 3,655,917 common stock at a price $2.325 per share for gross proceeds $8,500,007.025 and series G warrants to... has entered into securities definitive…
Bluejay Diagnostics, Inc. Completes Establishment of Manufacturing Site for Symphonytm Cartridges
Bluejay Diagnostics, Inc. completed the establishment of a manufacturing site for SymphonyTM cartridges, achieving a critical contractual milestone as the Company advances toward regulatory submission ... completed the establishment of a…
Bluejay Diagnostics Completes Enrollment in SYMON-II Clinical Validation Study
Bluejay Diagnostics completed enrollment ahead of schedule in the SYMON-II clinical validation study of its Symphony IL-6 sepsis diagnostic platform, the company said Tuesday. The study enrolled... Biotechnology & Medical Research Bluejay…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com7
- stocktitan.net1
- tradingview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 9 articles, not a forecast.